UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort

Acta dermato-venereologica, 2022-03, Vol.102, p.adv00665-adv00665

2022

Volltextzugriff (PDF)

Reply to: Comment on “Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa”

Journal of the American Academy of Dermatology, 2021-06, Vol.84 (6), p.e267-e268

2021

Volltextzugriff (PDF)

Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database

Journal of investigative dermatology, 2024-03, Vol.144 (3), p.708-710.e7

2024

Volltextzugriff (PDF)

Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database

Journal of the American Academy of Dermatology, 2022-02, Vol.86 (2), p.431-433

2022

Volltextzugriff (PDF)

Evolution of the spectrum of drugs associated with acute generalized exanthematous pustulosis over time: A pharmacovigilance study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.555-557

2024

Volltextzugriff (PDF)

Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis: A Single-Center Retrospective Study of 147 Patients

JAMA dermatology (Chicago, Ill.), 2023-03, Vol.159 (3), p.338

2023

Volltextzugriff (PDF)

Comparison of incidence, causes and prognosis of adult and pediatric epidermal necrolysis: a population-based study in France

British journal of dermatology (1951), 2024-06

2024

Volltextzugriff (PDF)

34927 Adverse events associated with dupilumab in the WHO pharmacovigilance

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB136-AB136

2022

Volltextzugriff (PDF)

Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study

The Lancet infectious diseases, 2021-10, Vol.21 (10), p.1441-1447

2021

Volltextzugriff (PDF)

Guttate psoriasis shares histological features with pustular psoriasis and often shows neutrophil exocytosis and pustules

Pathology, 2024-06, Vol.56 (4), p.606-608

2024

Volltextzugriff (PDF)

Adverse events associated with dupilumab in the WHO pharmacovigilance database

Journal of the American Academy of Dermatology, 2021-10, Vol.86 (2), p.P431-433

2021

Volltextzugriff (PDF)

Is ceftriaxone similarly effective to benzylpenicillin in neurosyphilis? – Authors' reply

The Lancet infectious diseases, 2021-09, Vol.21 (9), p.1207-1208

2021

Volltextzugriff (PDF)

Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases: an overview

Journal of clinical epidemiology, 2024-08, Vol.172, p.111411, Article 111411

2024

Volltextzugriff (PDF)

Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality

British journal of dermatology (1951), 2022-07, Vol.187 (1), p.29-41

2022

Volltextzugriff (PDF)

Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study

British journal of dermatology (1951), 2024-06

2024

Volltextzugriff (PDF)

Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020

Journal of the American Academy of Dermatology, 2021-12, Vol.85 (6), p.1581-1584

2021

Volltextzugriff (PDF)

Bullous pemphigoid: Three main clusters defining 3 outcome profiles

Journal of the American Academy of Dermatology, 2022-08, Vol.87 (2), p.359-365

2022

Volltextzugriff (PDF)

Cutaneous adverse drug reactions

Therapie, 2024-03, Vol.79 (2), p.239-270

2024

Volltextzugriff (PDF)

Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis

British journal of dermatology (1951), 2022-06, Vol.186 (6), p.1037-1039

2022

Volltextzugriff (PDF)

IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients

Journal of rheumatology, 2023-02, Vol.50 (2), p.252-257

2023

Volltextzugriff (PDF)

Novel inflammatory markers and in‐hospital mortality in epidermal necrolysis—A monocentric study of 137 patients

Journal of the European Academy of Dermatology and Venereology, 2023-03, Vol.37 (3), p.e382-e383

2023

Volltextzugriff (PDF)

Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis

Journal of the European Academy of Dermatology and Venereology, 2024-09, Vol.38 (9), p.1791-1798

2024

Volltextzugriff (PDF)

Efficacy and safety of treatments in cutaneous polyarteritis nodosa: A French observational retrospective study

Journal of the American Academy of Dermatology, 2022-05, Vol.86 (5), p.1035-1041

2022

Volltextzugriff (PDF)

Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa

Journal of the American Academy of Dermatology, 2020-11, Vol.83 (5), p.1441-1444

2020

Volltextzugriff (PDF)

Patch tests in non‐immediate cutaneous adverse drug reactions: Late readings on Day 4 is more sensitive than on Day 3

Contact dermatitis, 2024-07, Vol.91 (4), p.321-326

2024

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Kidney Journal

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(18)
Dermatology
(17)
Life Sciences
(12)
Retrospective Studies
(9)
Female
(6)
Pharmacovigilance
(6)
Adult
(5)
Human Health And Pathology
(5)
Male
(5)
Middle Aged
(5)
Psoriasis
(4)
Stevens-Johnson Syndrome - Epidemiology
(4)
Treatment
(4)
Adverse Drug Reaction Reporting Systems
(3)
Antibiotics
(3)
Clinical Trials
(3)
Databases, Factual
(3)
Inflammation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort

Reply to: Comment on “Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa”

Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database

Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database

Evolution of the spectrum of drugs associated with acute generalized exanthematous pustulosis over time: A pharmacovigilance study

Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis: A Single-Center Retrospective Study of 147 Patients

Comparison of incidence, causes and prognosis of adult and pediatric epidermal necrolysis: a population-based study in France

34927 Adverse events associated with dupilumab in the WHO pharmacovigilance

Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study

Guttate psoriasis shares histological features with pustular psoriasis and often shows neutrophil exocytosis and pustules

Adverse events associated with dupilumab in the WHO pharmacovigilance database

Is ceftriaxone similarly effective to benzylpenicillin in neurosyphilis? – Authors' reply

Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases: an overview

Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality

Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study

Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020

Bullous pemphigoid: Three main clusters defining 3 outcome profiles

Cutaneous adverse drug reactions

Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis

IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients

Novel inflammatory markers and in‐hospital mortality in epidermal necrolysis—A monocentric study of 137 patients

Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis

Efficacy and safety of treatments in cutaneous polyarteritis nodosa: A French observational retrospective study

Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa

Patch tests in non‐immediate cutaneous adverse drug reactions: Late readings on Day 4 is more sensitive than on Day 3

Aktive Filter

Suchergebnisse filtern